BMJ-BRIT MED J 润色咨询

BMJ-British Medical Journal

出版年份:暂无数据 年文章数:1625 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2024-02-09 15014e5643m 来自重庆

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2022-07-05 138299b15em

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?

    17

    展开17条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2023-07-04 122cba2dm74暂无昵称 来自安徽省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向:方法学;临床流行病
    经验分享:审稿严谨

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2023-01-26 来自福建省

    投稿17天,状态变成With Committee for Evaluation

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2022-06-29 weilai2015

    偏重的研究方向:循证医学;流行病学
    经验分享:投稿两个月了,还在外审......

    17

    展开17条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2022-07-20 ms9000001765004289

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:投了一个月 说我需要润色 英语太差拒稿

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2022-03-19 yinahao

    投稿命中率:5.0
    经验分享:已投七个月,返修两次,现在状态又重来一遍

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2022-03-22 138299b15em

    审稿速度:3.0
    经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2020-08-01 krygios

    替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2186681, encodeId=c4e92186681a3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇,一审6个审稿人,叫转投bmj m e d i c i n e,这个是新办的杂志,不晓得怎么样,什么时候有影响因子?会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Fri Feb 09 13:34:30 CST 2024, time=2024-02-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:文章已接受,版面Endgames,请问大侠们Endgames版面从接受到proof需要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:方法学;临床流行病<br>经验分享:审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天,状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向:循证医学;流行病学<br>经验分享:投稿两个月了,还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享:已投七个月,返修两次,现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享:投稿两月余,这段时间awaiting reviewer scores后变成 with with committee for evaluation,后来两天又变成awaiting reviewer scores,大侠们知道什么情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=836, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿,邮件时间一个月,系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿,邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改,时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑,目前等待proof,感谢一起努力的三位伙伴,铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=714, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向:Clinical Research<br>经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。<br>找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=)]
    2020-12-05 ms1000001266658240

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0
    偏重的研究方向:Clinical Research
    经验分享:8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下,觉得我们的abstract写的不够吸引人,可能没有引起editor的注意,然后提交了resubmission,相当于appeal against the intial editorial decision,意思就是说我们的研究还是值得你们仔细看一看 (目前在五大临床刊里只有BMJ提供这个选项,不要轻易使用,只有当你有理由认为你的研究值得BMJ发表的情况下再使用)。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见,比如reviewer认为你的研究不应该被收录,但给的理由不对,这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低,BMJ也不推荐。幸运的是在我们appeal了以后,另一个editor给了positive的意见,然后文章进入了external review阶段(给editor点个赞)。
    找reviewer一周,审稿两周,editorial decision又两周,10月初给了revision。Editor和reviewer都非常负责,9页纸的comments,花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态,一直是等待reviewer和editor的分配(怀疑工作人员休假去了)。12月初,正在我们各种吐槽这一轮为何如此之慢的时候,editor的邮件来了,给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。
    BMJ的速度相对JAMA来说慢一些,不过他们会把editorial meeting对你的文章的comments都记录下来发给你,非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀(相对杂志的地位,估计大家都不会在意这个了哈哈)。

    1

    展开1条回复
共116条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分